IMPROVING THE PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN METASTATIC MELANOMA BY COMBINING PLOIDY AND S-PHASE FRACTION

被引:2
|
作者
MUHONEN, T
机构
[1] Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Helsinki, SF-00290
关键词
DNA; FLOW CYTOMETRY; MELANOMA; MELANOMA MORTALITY; PLOIDY; S-PHASE FRACTION;
D O I
10.1097/00008390-199211000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of cellular DNA content of melanoma metastases was investigated in tumours from 114 consecutive patients referred to the Helsinki University Central Hospital Melanoma Team. Thirty-six percent of the tumours were diploid and 64% aneuploid. For 91 patients the S-phase fraction was calculable. Tumour ploidy and S-phase fraction (SPF) were shown by multivariate Cox model analysis to be independent prognostic variables and major determinants of survival after first recurrence. Patients with either aneuploid or low SPF tumours survived longer than did those with diploid or high SPF tumours. By combining DNA ploidy and SPF, three types of DNA histograms could be defined, associated with favourable, intermediate and poor prognosis. Patients with aneuploid, low SPF metastases showed a median survival of 57 months, whereas the high-risk group with diploid, high SPF metastases survived only 13 months. When ploidy, SPF, age, sex, TNM stage and duration of disease-free survival were analysed as covariates the division of flow cytometry histograms into these three types resulted in the most significant prognostic factor (p<0.001) in the Cox multivariate analysis.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [41] QUALITY-CONTROL OF S-PHASE FRACTION IN MULTIPARAMETRIC 2-COLOR DNA FLOW-CYTOMETRY OF SOLID TUMORS
    LINDEN, MD
    BROWN, RD
    KUBUS, J
    SCHULTZ, DS
    ZARBO, RJ
    LABORATORY INVESTIGATION, 1992, 66 (01) : A119 - A119
  • [42] PROGNOSTIC IMPLICATIONS OF TUMOR PLOIDY AND PROLIFERATIVE ACTIVITY AS MEASURED BY DNA FLOW-CYTOMETRY
    BARLOGIE, B
    JOHNSTON, DA
    RABER, MN
    DREWINKO, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 335 - 335
  • [43] DNA PLOIDY AND S-PHASE FRACTION IN RECTAL-CANCER
    WARNER, S
    HARRISON, J
    VANDERZWAAG, R
    ELZEKY, F
    RABINOVITCH, P
    DEAN, P
    LABORATORY INVESTIGATION, 1991, 64 (01) : A41 - A41
  • [44] LACK OF PROGNOSTIC-SIGNIFICANCE OF DNA PLOIDY AND S-PHASE FRACTION IN BREAST-CANCER
    STANTON, PD
    COOKE, TG
    OAKES, SJ
    WINSTANLEY, J
    HOLT, S
    GEORGE, WD
    MURRAY, GD
    BRITISH JOURNAL OF CANCER, 1992, 66 (05) : 925 - 929
  • [45] PROGNOSTIC VALUE OF ANALYSIS OF DNA IN PANCREATIC ADENOCARCINOMA BY FLOW-CYTOMETRY
    HYOTY, M
    VISAKORPI, T
    KALLIONIEMI, OP
    MATTILA, J
    LAIPPALA, P
    NORDBACK, I
    ACTA CHIRURGICA-THE EUROPEAN JOURNAL OF SURGERY, 1991, 157 (10): : 595 - 600
  • [46] DNA ploidy and S-phase in recurrent astrocytomas: A retrospective study by flow cytometry of deparaffinized specimens
    Vavruch, L
    Nordenskjold, B
    Carstensen, J
    Enestrom, S
    JOURNAL OF NEURO-ONCOLOGY, 1996, 30 (01) : 37 - 45
  • [47] PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN THYMOMAS AND THYMIC CARCINOMAS
    SAUTER, ER
    SARDI, A
    HOLLIER, LH
    COOPER, ES
    BOLTON, JS
    SOUTHERN MEDICAL JOURNAL, 1990, 83 (06) : 656 - 659
  • [48] Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma
    Karlsson, M
    Boeryd, B
    Carstensen, J
    Franlund, B
    Gustafsson, B
    Kagedal, B
    Sun, XF
    Wingren, S
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (02) : 357 - 362
  • [49] Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer
    Lundin, J
    Nordling, S
    VonBoguslawsky, K
    Roberts, PJ
    Haglund, C
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2659 - 2668
  • [50] Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer
    Tetu, B
    Allard, P
    Fradet, Y
    Roberge, N
    Bernard, P
    HUMAN PATHOLOGY, 1996, 27 (09) : 922 - 926